Directors and Executives

The Directors and Executives team at Nyxoah oversees strategic decision-making, leadership, and governance, ensuring the effective development and commercialization of hypoglossal nerve stimulation (HGNS) therapy. This team sets corporate objectives, aligns operational activities with company goals, and maintains regulatory and quality compliance, driving innovation and growth within the medical device industry.